European guidelines on the clinical management of HIV-1 tropism testing.
about
HIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategiesBioinformatic analysis of HIV-1 entry and pathogenesis.Individualization of antiretroviral therapy--pharmacogenomic aspectMonophylogenetic HIV-1C epidemic in Ethiopia is dominated by CCR5-tropic viruses-an analysis of a prospective country-wide cohortHIV-1 subtype D infections among Caucasians from Northwestern Poland--phylogenetic and clinical analysisAnalysis of physicochemical and structural properties determining HIV-1 coreceptor usageHigh proportion of HIV serodiscordance among HIV-affected married couples in northern VietnamParameters Influencing Baseline HIV-1 Genotypic Tropism Testing Related to Clinical Outcome in Patients on MaravirocRecent Transmission Clustering of HIV-1 C and CRF17_BF Strains Characterized by NNRTI-Related Mutations among Newly Diagnosed Men in Central ItalyA Follow-Up of the Multicenter Collaborative Study on HIV-1 Drug Resistance and Tropism Testing Using 454 Ultra Deep PyrosequencingRoutine use of microbial whole genome sequencing in diagnostic and public health microbiologyHIV-1 tropism dynamics and phylogenetic analysis from longitudinal ultra-deep sequencing data of CCR5- and CXCR4-using variants.X4 viruses are frequently archived in patients with long-term HIV infection but do not seem to influence the "inflamm-aging" process.Emergence of CXCR4-tropic HIV-1 variants followed by rapid disease progression in hemophiliac slow progressors.A genotypic HIV-1 proviral DNA coreceptor tropism assay: characterization in viremic subjects.Limited evolution of inferred HIV-1 tropism while viremia is undetectable during standard HAART therapyDetermination of viral tropism by genotyping and phenotyping assays in Brazilian HIV-1-infected patients.Association between HIV-1 tropism and CCR5 human haplotype E in a Caucasian population.Geno2pheno[454]: a Web server for the prediction of HIV-1 coreceptor usage from next-generation sequencing data.Coreceptor usage, diversity, and divergence in drug-naive and drug-exposed individuals from Malawi, infected with HIV-1 subtype C for more than 20 years.An expanded model of HIV cell entry phenotype based on multi-parameter single-cell data.A genotypic test for HIV-1 tropism combining Sanger sequencing with ultradeep sequencing predicts virologic response in treatment-experienced patientsGenotypic prediction of tropism of highly diverse HIV-1 strains from CameroonHIV-1 tropism: a comparison between RNA and proviral DNA in routine clinical samples from Chilean patientsThe genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing.High prevalence of CXCR4 usage among treatment-naive CRF01_AE and CRF51_01B-infected HIV-1 subjects in Singapore.HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected].A case-based reasoning system for genotypic prediction of HIV-1 co-receptor tropism.Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages.A diagnostic HIV-1 tropism system based on sequence relatedness.Stability of unfrozen whole blood DNA for remote genotypic analysis of HIV-1 coreceptor tropism.Evidence that HIV-1 CRF01_AE is associated with low CD4+T cell count and CXCR4 co-receptor usage in recently infected young men who have sex with men (MSM) in Shanghai, China.Impact of mutations outside the V3 region on coreceptor tropism phenotypically assessed in patients infected with HIV-1 subtype BDetermination of HIV-1 coreceptor tropism using proviral DNA in women before and after viral suppressionRecent HIV-1 Outbreak Among Intravenous Drug Users in Romania: Evidence for Cocirculation of CRF14_BG and Subtype F1 Strains.Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized TrialCRF19_cpx is an Evolutionary fit HIV-1 Variant Strongly Associated With Rapid Progression to AIDS in Cuba.Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 Usage.Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.Genotypic Tropism Testing in HIV-1 Proviral DNA Can Provide Useful Information at Low-Level Viremia.
P2860
Q26825087-3B4FF844-37CB-4CBA-BA42-723C5F568D12Q27693321-B9389F0A-3A6B-4AC3-9DEE-0B08358EE5D8Q28070574-0F714B27-7107-4A02-B326-1516E8989C76Q28365077-5EF572BF-8F10-464B-B069-ACF9D493CD65Q28480877-8E40747F-9216-4313-BD55-2EC61C31D6D1Q28488611-9E05E6ED-B749-4349-98D4-AC97CFBE9DA3Q28546629-FD77CCD1-BD3D-4B30-885A-DC7AEFDD9367Q28547216-4D5C3EE4-C079-4B97-888C-D3EEC213887BQ28547222-32FEB757-CCB1-4A72-896C-B06F9A6FF885Q28552356-EB4463F0-EA12-43AD-A6E9-50001EE1717AQ28728617-49D654AF-1DD3-4CED-BF9F-E07650EC21BDQ30836893-B60D73CF-A43D-42F1-B6E7-3E9A3EA23550Q31117473-1929CC29-8AC8-4B55-9E83-A0A9E5624D06Q33638001-C5846A28-C573-470F-94C1-FF7201D9D778Q33712327-5164C2F9-80F9-452A-B8A6-026C1590E105Q33721466-1C104245-FE21-4EC8-BD04-BC6463DB7F52Q34040770-B9F665F3-1EB7-4995-91E7-B121BDFE5256Q34098010-C972417F-D213-4A4C-964B-B4FE48159AC3Q34144135-B2A99057-F373-477D-B319-9F60BE6261B0Q34269253-1268D17D-8628-4B6C-A952-5537F77E1A9BQ34351378-4B853B74-3A01-4144-9689-65989A87214EQ34431102-DF73FAA6-2982-4142-ACF1-21D50B3C210EQ34473354-72C065D5-FF16-49A3-B365-97386C87B051Q34508492-25C0FA32-7B81-48AD-86EA-D0BE5F0D5C42Q34558508-976C8BE3-7490-4706-B883-DEB6F435748EQ34591699-33610A3D-8A98-47C8-B79E-69AA6889432DQ34716813-19763966-0069-4433-9BE7-0A10DDCA36B5Q34823507-D895BA4B-890F-445C-8F47-1104CB5A37CBQ34846620-B5E7C19A-1EA2-459A-869C-CB04886939ACQ34983107-97ED4870-8C9E-448F-ACB1-EA6B1FA6BCCFQ35029040-7AFD0668-9D15-473D-9108-1CF862DB0F91Q35107377-40942EB5-2CB6-490C-B877-C37EB1B2787CQ35364051-76EE498A-D80B-4E85-84B0-7E24771E794FQ35491675-F1182566-6DF0-4F9D-A820-78E26C8F0F9DQ35589809-1117F6D2-7B7C-4AA1-B205-7E1F027CE69DQ35712284-09F35F2F-171C-4CA7-BF5D-E17BF87635E7Q35795095-8A25F102-AA6D-4ABD-A0F7-6FADE99215D9Q35859926-DD7E9420-C1FC-46A4-92E2-39C92AF5C168Q35953203-10FED990-2171-420A-95F6-97255B46036AQ35968753-A2FC5C29-E5FA-492C-980C-0CF993B5C2BB
P2860
European guidelines on the clinical management of HIV-1 tropism testing.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
European guidelines on the clinical management of HIV-1 tropism testing.
@en
European guidelines on the clinical management of HIV-1 tropism testing.
@nl
type
label
European guidelines on the clinical management of HIV-1 tropism testing.
@en
European guidelines on the clinical management of HIV-1 tropism testing.
@nl
prefLabel
European guidelines on the clinical management of HIV-1 tropism testing.
@en
European guidelines on the clinical management of HIV-1 tropism testing.
@nl
P2093
P50
P1476
European guidelines on the clinical management of HIV-1 tropism testing.
@en
P2093
A M Geretti
A M J Wensing
A Sönnerborg
A-M Vandamme
B Masquelier
C A B Boucher
C Verhofstede
P304
P356
10.1016/S1473-3099(10)70319-4
P577
2011-03-21T00:00:00Z